Scalper1 News
A lot’s been going on with specialty drugmaker Horizon Pharma — so much that it’s almost a different company from what it was 12 months ago. Last July, Horizon (HZNP) learned that Express Scripts (ESRX) and CVS ‘ (CVS) Caremark were knocking its flagship drugs Vimovo and Duexis off their preferred-formulary lists on the grounds that both drugs, which combine treatments for arthritis pain with other medicines protecting against the painkillers’ Scalper1 News
Scalper1 News